News|Webcasts|February 4, 2026

Shaping the Future of Microbial Development: From Gene to GMP

Author(s)Fujifilm
Listen
0:00 / 0:00

Webinar Date/Time: Tue, Feb 24, 2026 11:00 AM EST

Discover proven strategies and innovative technologies to streamline microbial development, from early studies to GMP readiness. Learn from industry experts how to boost productivity, overcome bottlenecks, and move therapies to patients faster.

Register Free: https://www.biopharminternational.com/bp_w/gene_to_gmp

Event Overview:

In today’s fast-paced biopharmaceutical industry, accelerating microbial process development is critical for moving from gene to good manufacturing process (GMP) with greater speed and efficiency. This webinar will highlight strategies to streamline development timelines, with a focus on adopting innovative approaches and technologies. You’ll hear how leading experts are optimizing microbial fermentation, scaling production while meeting regulatory requirements, and preparing for smoother transitions from early studies to GMP readiness. Join us to discover how smarter, faster process development can help you bring therapies to patients more effectively.

Key Learning Objectives:

  • Proven strategies to overcome common challenges and bottlenecks
  • Techniques to boost productivity and shorten time to market
  • Practical solutions for advancing microbial processes efficiently
  • Methods to enable quicker transitions to toxicology trials and GMP manufacturing
  • Perspectives on the future of expedited microbial downstream processing

Who should Attend:

  • Large and small biotech companies and spin outs
  • Anyone with CMC or procurement in their titles
  • Technical directors
  • CSOS
  • Consultants


Speaker:

Steve Loftus, PhD
Director, Commercial Technical Lead for Biologics
FUJIFILM Biotechnologies

Steve Loftus, PhD, serves as director, commercial technical lead for biologics at FUJIFILM Biotechnologies. With over 19 years in the biotechnology industry, he excels in strategic growth and project management, focusing on mammalian cell culture and microbial service offerings. Loftus plays a pivotal role in solution-based selling, aligning technical offerings with client needs, and guiding FUJIFILM Biotechnologies to industry leadership. Loftus holds a PhD in biochemistry/biophysics from the University of York and a degree in medical microbiology from the University of Newcastle.

Register Free: https://www.biopharminternational.com/bp_w/gene_to_gmp

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.